story of the week
Stereotactic Ablative Body Radiotherapy in Patients With Oligometastatic Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Stereotactic Ablative Body Radiotherapy in Patients With Oligometastatic Cancers: A Prospective, Registry-Based, Single-Arm, Observational, Evaluation Study
Lancet Oncol 2021 Jan 01;22(1)98-106, A Chalkidou, T Macmillan, MT Grzeda, J Peacock, J Summers, S Eddy, B Coker, H Patrick, H Powell, L Berry, G Webster, P Ostler, PD Dickinson, MQ Hatton, A Henry, S Keevil, MA Hawkins, N Slevin, N van AsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.